SELLAS Life Sciences Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-09-30 was 0.00 shares.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-12-31 was -159.00K shares.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 8.00K shares, a 79.49% decline from fiscal 2015.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 39.00K shares.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2013 was 289.00K shares, a 1014.24% increase from fiscal 2012.
- SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2012 was 25.94K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -159.00K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -159.00K shares derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-10 | -32.00K shares derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | -159.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | 8.00K shares 10-K · filed 2017-03-15 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 167.00K shares derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-06-30 | 127.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 205.00K shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 40.00K shares 10-Q · filed 2016-05-10 | 79.00K shares derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-04-15 | 39.00K shares 10-K/A · filed 2016-04-15 |
| 2015-09-30 | 38.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 39.00K shares derived: sum of 4 quarters · filed 2015-12-04 |
| 2015-06-30 | 1.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 281.00K shares derived: sum of 4 quarters · filed 2015-12-04 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-07 | 292.00K shares derived: sum of 4 quarters · filed 2015-12-04 |
| 2014-12-31 | 0.00 shares derived: 8-K 12 month − 10-Q 9 month · filed 2015-12-04 | 3.61M shares 8-K · filed 2015-12-04 |
| 2014-09-30 | 280.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | 3.89M shares derived: sum of 4 quarters · filed 2014-11-05 |
| 2014-06-30 | 12.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 3.61M shares derived: sum of 4 quarters · filed 2014-08-11 |
| 2014-03-31 | 3.32M shares 10-Q · filed 2014-05-06 | |
| 2013-12-31 | 279.00K shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-17 | 289.00K shares 10-K · filed 2014-03-17 |
| 2013-09-30 | 2.00K shares derived: 10-Q/A 9 month − 10-Q 6 month · filed 2013-11-07 | |
| 2012-12-31 | 37.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | 25.94K shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |